Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

medicalresearch.com

These findings suggest that the clinical benefits of proton pump inhibitors use against the excess risks of cardiovascular events and mortality should be taken into consideration among patients with type 2 diabetes.